Advertisement

AIDS and Behavior

, Volume 23, Issue 7, pp 1824–1832 | Cite as

Vulnerable at Each Step in the PMTCT Care Cascade: High Loss to Follow Up During Pregnancy and the Postpartum Period in Tanzania

  • Cody Cichowitz
  • Festo Mazuguni
  • Linda Minja
  • Prosper Njau
  • Gretchen Antelman
  • James Ngocho
  • Brandon A. Knettel
  • Melissa H. Watt
  • Blandina T. MmbagaEmail author
Original Paper

Abstract

In 2013, Tanzania adopted the World Health Organization’s Option B+ guidelines for prevention of mother-to-child transmission of HIV (PMTCT), whereby all HIV-infected pregnant women initiate lifelong antiretroviral therapy. This study examined retention in PMTCT across critical junctures in the care continuum. This was a retrospective study of patient-level data for a cohort of women enrolled in PMTCT during the first year of Option B+ in Tanzania. Retention in care was described across three periods: (1) the first month of antenatal care (ANC), (2) pregnancy, and (3) the postpartum period. Logistic regression was used to identify factors associated with loss to follow up (LTFU) during the first month of ANC. Survival analyses were used to identify factors associated with LTFU during pregnancy and the postpartum periods. 650 participants were included in the cohort; 262 (40.3%) were newly diagnosed with HIV. Two years after delivery, 383/650 (58.7%) were LTFU. Of the 383 LTFU, 73 (19.1%) were lost during the first month of ANC, 44 (11.5%) during pregnancy, and 266 (69.5%) after delivery. Being newly diagnosed with HIV predicted higher LTFU during the first month of ANC (aOR 1.76; 95% CI 1.06–2.94) and faster time to LTFU during the postpartum period (adjusted relative time, 0.68; 95% CI 0.51–0.89). High LTFU occurred across the PMTCT continuum, including immediately after enrollment into ANC and the postpartum period. Ongoing research is needed to encourage treatment uptake and sustained engagement after delivery.

Keywords

PMTCT HIV Retention in care LTFU Option B+ Tanzania 

Notes

Acknowledgements

This study was supported by a grant from the NIH National Institute of Allergies and Infectious Diseases (NIAID): Postpartum HIV care engagement in the context of Option B+ in Tanzania (R21 AI124344, MPI Watt/Mmbaga). Additionally, this work was supported in part by the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at Duke University; Cody Cichowitz is a Doris Duke International Clinical Research Fellow. Finally, we acknowledge support received from the Duke Center for AIDS Research (P30 AI064518). None of the funders had any involvement in the study or the preparation of this manuscript.

Compliance with Ethical Standards

Conflict of interest

The authors declare no conflicts of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Supplementary material

10461_2018_2298_MOESM1_ESM.docx (22 kb)
Supplementary material 1 (DOCX 22 kb)

References

  1. 1.
    UNAIDS. On the fast-track to an AIDS-free generation. 2016. http://www.unaids.org/sites/default/files/media_asset/GlobalPlan2016_en.pdf (accessed November 14, 2017).
  2. 2.
    World Health Organization. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2012. http://www.who.int/hiv/PMTCT_update.pdf (accessed November 14, 2017).
  3. 3.
    Geldsetzer P, Yapa HMN, Vaikath M, Ogbuoji O, Fox MP, Essajee SM, et al. A systematic review of interventions to improve postpartum retention of women in PMTCT and ART care. J Int AIDS Soc. 2016;19(1):20679.CrossRefGoogle Scholar
  4. 4.
    Black S, Zulliger R, Marcus R, Mark D, Myer L, Bekker L-G. Acceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa. AIDS Care. 2014;26(6):736–41.CrossRefGoogle Scholar
  5. 5.
    Knettel BA, Cichowitz C, Ngocho JS, Knippler ET, Chumba LN, Mmbaga BT, et al. Retention in HIV care during pregnancy and the postpartum period in the Option B+ era: a systematic review and meta-analysis of studies in Africa. J Acquir Immune Defic Syndr. 2018;77(5):427–38.CrossRefGoogle Scholar
  6. 6.
    Kalua T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, Schouten EJ, Gupta S, et al. Lessons learned from Option B+ in the evolution toward “test and start” from Malawi, Cameroon, and the United Republic of Tanzania. J Acquir Immune Defic Syndr. 2017;75(Suppl 1):S43–50.CrossRefGoogle Scholar
  7. 7.
    Gwadz M, Cleland CM, Applegate E, Belkin M, Gandhi M, Salomon N, et al. Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav. 2015;19(10):1801–17.CrossRefGoogle Scholar
  8. 8.
    Haberer JE, Sabin L, Amico KR, Orrell C, Galarraga O, Tsai AC, et al. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017;20(1):21371.CrossRefGoogle Scholar
  9. 9.
    Gill MM, Umutoni A, Hoffman HJ, Ndatimana D, Ndayisaba GF, Kibitenga S, et al. Understanding antiretroviral treatment adherence among HIV-positive women at four postpartum time intervals: qualitative results from the Kabeho Study in Rwanda. AIDS Patient Care STDS. 2017;31(4):153–66.CrossRefGoogle Scholar
  10. 10.
    Elwell K. Facilitators and barriers to treatment adherence within PMTCT programs in Malawi. AIDS Care. 2016;28(8):971–5.CrossRefGoogle Scholar
  11. 11.
    Cataldo F, Chiwaula L, Nkhata M, van Lettow M, Kasende F, Rosenberg NE, et al. Exploring the experiences of women and health care workers in the context of PMTCT Option B Plus in Malawi. J Acquir Immune Defic Syndr. 2017;74(5):517–22.CrossRefGoogle Scholar
  12. 12.
    Buregyeya E, Naigino R, Mukose A, Makumbi F, Esiru G, Arinaitwe J, et al. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017;17(1):94.CrossRefGoogle Scholar
  13. 13.
    Tweya H, Gugsa S, Hosseinipour M, Speight C, Ngambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Trop Med Int Health. 2014;19(11):1360–6.CrossRefGoogle Scholar
  14. 14.
    Napua M, Pfeiffer JT, Chale F, Hoek R, Manuel J, Michel C, et al. Option B+ in Mozambique: formative research findings for the design of a facility-level clustered randomized controlled trial to improve ART retention in antenatal care. J Acquir Immune Defic Syndr. 2016;72(Suppl 2):S181–8.CrossRefGoogle Scholar
  15. 15.
    Dow DE, Turner EL, Shayo AM, Mmbaga B, Cunningham CK, O’Donnell K. Evaluating mental health difficulties and associated outcomes among HIV-positive adolescents in Tanzania. AIDS Care. 2016;28(7):825–33.CrossRefGoogle Scholar
  16. 16.
    Dzangare J, Takarinda KC, Harries AD, Tayler-Smith K, Mhangara M, Apollo TM, et al. HIV testing uptake and retention in care of HIV-infected pregnant and breastfeeding women initiated on “Option B+” in rural Zimbabwe. Trop Med Int Health. 2016;21(2):202–9.CrossRefGoogle Scholar
  17. 17.
    Myer L, Phillips TK. Beyond “Option B+”: understanding antiretroviral therapy (ART) adherence, retention in care and engagement in ART services among pregnant and postpartum women initiating therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2017;1(75 Suppl 2):S115–22.CrossRefGoogle Scholar
  18. 18.
    Psaros C, Remmert JE, Bangsberg DR, Safren SA, Smit JA. Adherence to HIV care after pregnancy among women in sub-Saharan Africa: falling off the cliff of the treatment cascade. Curr HIVAIDS Rep. 2015;12(1):1–5.CrossRefGoogle Scholar
  19. 19.
    The United Republic of Tanzania Ministry of Health and Social Welfare. National guidelines for comprehensive care services for prevention of mother-to-child transmission of HIV and keeping mothers alive. 2013. http://ihi.eprints.org/3335/1/tz_guidelines_ccs_optionb_all.pdf (accessed May 22, 2017).
  20. 20.
    The United Republic of Tanzania Ministry of Health and Social Welfare. Tanzania elimination of mother to child transmission of HIV plan 2012-2015. 2012. http://www.healthpromotiontanzania.org/index.php/en/library122/doc_view/152-costed-emtct-plan-final-16-may-2.html (accessed October 13, 2017).
  21. 21.
    Atanga PN, Ndetan HT, Achidi EA, Meriki HD, Hoelscher M, Kroidl A. Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating “Option B+” in the South West Region. Trop Med Int Health. 2017;22(2):161–70.CrossRefGoogle Scholar
  22. 22.
    Auld AF, Shiraishi RW, Couto A, Mbofana F, Colborn K, Alfredo C, et al. A decade of antiretroviral therapy scale-up in Mozambique: evaluation of outcome trends and new models of service delivery among more than 300,000 patients enrolled during 2004–2013. J Acquir Immune Defic Syndr. 2016;73(2):e11–22.CrossRefGoogle Scholar
  23. 23.
    Haas AD, Tenthani L, Msukwa MT, Tal K, Jahn A, Gadabu OJ, et al. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi’s Option B+ programme: an observational cohort study. Lancet HIV. 2016;3(4):e175–82.CrossRefGoogle Scholar
  24. 24.
    Hoffman RM, Phiri K, Parent J, Grotts J, Elashoff D, Kawale P, et al. Factors associated with retention in Option B+ in Malawi: a case control study. J Int AIDS Soc. 2017;20(1):21464.CrossRefGoogle Scholar
  25. 25.
    Mitiku I, Arefayne M, Mesfin Y, Gizaw M. Factors associated with loss to follow-up among women in Option B+ PMTCT programme in northeast Ethiopia: a retrospective cohort study. J Int AIDS Soc. 2016;19(1):20662.CrossRefGoogle Scholar
  26. 26.
    Cox C, Chu H, Schneider MF, Muñoz A. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med. 2007;26(23):4352–74.CrossRefGoogle Scholar
  27. 27.
    StataCorp. Stata statistical software: release 15. College Station, TX: StataCorp, LLC; 2017.Google Scholar
  28. 28.
    Ford D, Muzambi M, Nkhata MJ, Abongomera G, Joseph S, Ndlovu M, et al. Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV + women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience. J Acquir Immune Defic Syndr. 2017;74(5):508–16.CrossRefGoogle Scholar
  29. 29.
    Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016;19(1):21484.CrossRefGoogle Scholar
  30. 30.
    Grimsrud A, Lesosky M, Kalombo C, Bekker L-G, Myer L. Implementation and operational research: community-based adherence clubs for the management of stable antiretroviral therapy patients in Cape Town, South Africa: a cohort study. J Acquir Immune Defic Syndr. 2016;71(1):e16–23.Google Scholar
  31. 31.
    Myer L, Iyun V, Zerbe A, Phillips TK, Brittain K, Mukonda E, et al. Differentiated models of care for postpartum women on antiretroviral therapy in Cape Town, South Africa: a cohort study. J Int AIDS Soc. 2017;20(Suppl 4):21636.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Cody Cichowitz
    • 1
    • 2
    • 4
  • Festo Mazuguni
    • 3
  • Linda Minja
    • 4
  • Prosper Njau
    • 3
    • 5
  • Gretchen Antelman
    • 6
  • James Ngocho
    • 3
    • 4
  • Brandon A. Knettel
    • 1
  • Melissa H. Watt
    • 1
  • Blandina T. Mmbaga
    • 4
    • 7
    Email author
  1. 1.Duke Global Health InstituteDuke UniversityDurhamUSA
  2. 2.Johns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Kilimanjaro Christian Medical University CollegeMoshiTanzania
  4. 4.Kilimanjaro Clinical Research InstituteMoshiTanzania
  5. 5.Prevention of Mother-to-Child Transmission HIV and National AIDS Control Program, Ministry of Health, Community Development, Gender, Elderly, and ChildrenDar es SalaamTanzania
  6. 6.Elizabeth Glaser Pediatric AIDS FoundationDar es SalaamTanzania
  7. 7.Kilimanjaro Christian Medical CentreMoshiTanzania

Personalised recommendations